Christopher Gibson - Mar 2, 2023 Form 4 Insider Report for RECURSION PHARMACEUTICALS, INC. (RXRX)

Signature
/s/ Jonathan Golightly, attorney-in-fact
Stock symbol
RXRX
Transactions as of
Mar 2, 2023
Transactions value $
-$166,268
Form type
4
Date filed
3/6/2023, 05:07 PM
Previous filing
Feb 17, 2023
Next filing
Mar 10, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RXRX Class A Common Stock Conversion of derivative security $0 +18.5K +1.97% $0.00 956K Mar 2, 2023 Direct F1, F2
transaction RXRX Class A Common Stock Sale -$147K -18.5K -1.93% $7.92 941K Mar 2, 2023 Direct F1, F3
transaction RXRX Class A Common Stock Conversion of derivative security $0 +500 $0.00 500 Mar 2, 2023 by LAHWRAN-3 LLC F1, F2, F4
transaction RXRX Class A Common Stock Sale -$3.95K -500 -100% $7.90 0 Mar 2, 2023 by LAHWRAN-3 LLC F1, F4, F5
transaction RXRX Class A Common Stock Conversion of derivative security $0 +1K $0.00 1K Mar 2, 2023 by LAHWRAN-4 LLC F1, F2, F6
transaction RXRX Class A Common Stock Sale -$7.91K -1K -100% $7.91 0 Mar 2, 2023 by LAHWRAN-4 LLC F1, F6, F7
transaction RXRX Class A Common Stock Conversion of derivative security $0 +1K $0.00 1K Mar 2, 2023 by Gibson Family Trust F1, F2, F8
transaction RXRX Class A Common Stock Sale -$7.91K -1K -100% $7.91 0 Mar 2, 2023 by Gibson Family Trust F1, F8, F9

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RXRX Class B Common Stock Conversion of derivative security $0 -18.5K -0.28% $0.00 6.62M Mar 2, 2023 Class A Common Stock 18.5K $0.00 Direct F1, F2, F13
transaction RXRX Class B Common Stock Conversion of derivative security $0 -500 -0.09% $0.00 539K Mar 2, 2023 Class A Common Stock 500 $0.00 by LAHWRAN-3 LLC F1, F2, F4, F13
transaction RXRX Class B Common Stock Conversion of derivative security $0 -1K -0.19% $0.00 528K Mar 2, 2023 Class A Common Stock 1K $0.00 by LAHWRAN-4 LLC F1, F2, F6, F13
transaction RXRX Class B Common Stock Conversion of derivative security $0 -1K -0.79% $0.00 125K Mar 2, 2023 Class A Common Stock 1K $0.00 by Gibson Family Trust F1, F2, F8, F13
holding RXRX Stock Option (Right to Buy) 814K Mar 2, 2023 Class A Common Stock 0 $8.55 Direct F10
holding RXRX Stock Option (Right to Buy) 5.44K Mar 2, 2023 Class A Common Stock 0 $11.40 Direct
holding RXRX Stock Option (Right to Buy) 416K Mar 2, 2023 Class A Common Stock 0 $11.40 Direct F11
holding RXRX Stock Option (Right to Buy) 781K Mar 2, 2023 Class A Common Stock 0 $2.48 Direct F12
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2 Represents the conversion of Class B Common Stock into Class A Common Stock.
F3 This transaction was executed in multiple trades at prices ranging from $7.73 to $8.06. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F4 The shares are held by LAHWRAN-3 LLC, of which the Reporting Person is a member and a manager.
F5 This transaction was executed in multiple trades at prices ranging from $7.73 to $8.05. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F6 The shares are held by LAHWRAN-4 LLC, of which the Reporting Person is a member and a manager.
F7 This transaction was executed in multiple trades at prices ranging from $7.74 to $8.05. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F8 The shares are held by the Gibson Family Trust, of which the Reporting Person serves as Trustee.
F9 This transaction was executed in multiple trades at prices ranging from $7.75 to $8.05. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F10 The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2023, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
F11 The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2022, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
F12 The option, originally for 1,500,000 shares, vested as to one forty-eighth (1/48th) of the shares subject to the option on January 31, 2021, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter.
F13 Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.